Developer docs
API playgroundTry for free, no card

Search company profiles

SALF

Full company profile

uuid000aarp

Namestring
SALF
Websiteurl
salfspa.it
Company typeenum
Private
Founded yearint
1921
Descriptiontext

SALF is a privately-held Italian pharmaceutical manufacturer headquartered in Bergamo, Italy, founded in 1921. With a workforce of 101–250 employees, the company operates as a mid-sized for-profit manufacturer producing human medicines, veterinary drugs, and medical equipment, supported by in-house ongoing research. Its product portfolio therefore spans three regulated categories — ethical/generic pharmaceuticals, animal health products, and medical devices — implying an integrated R&D-to-manufacturing operating model within a single Italian site.

The company's business model is anchored in regulated B2B and B2B2C distribution of pharmaceutical and veterinary products and medical devices, but no specific pricing model, channel structure, customer mix, or revenue mechanic was returned in the available data. SALF's public website (salfspa.it) did not yield substantive content during this data collection — the source page displayed only a loading/verification message — and consequently fields covering products, certifications, partnerships, management team, funding, M&A, AI capability, and customer base returned no values.

Given the thinness of the input, claims about market positioning, revenue scale, geographic footprint, capital structure, or competitive strategy cannot be substantiated beyond the firmographic facts above. Any further analysis would require access to the company's filings, distributor agreements, or audited financials, none of which were provided.

Short descriptiontext

SALF is a Bergamo, Italy-based pharmaceutical manufacturer founded in 1921 that develops and produces medicines, veterinary drugs, and medical equipment through in-house research, employing 101-250 people.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBergamo, Italy
HQ citystring
Bergamo
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
pharmaceutical manufacturing, veterinary medicines, medical equipment, human medicines production, pharmaceutical research
Industry2 codes
1Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid)
CodeHLAMAEAGPrimaryYes
2Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers)
CodeHLAMAFAFPrimaryNo
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
Cost components7 values
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

SALF is a pharmaceutical manufacturer that develops, produces, and supplies human medicines, veterinary drugs, and medical equipment. The company's offering is built on ongoing in-house pharmaceutical research, formulation, and manufacturing capabilities, delivering finished pharmaceutical and medical products to healthcare and animal health markets.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1Human medicines
CategoryPharmaceuticals
Description

Pharmaceutical products manufactured by SALF for human therapeutic use, produced through ongoing research and produced at the company's Bergamo, Italy facility for distribution to healthcare buyers.

2Veterinary drugs
CategoryVeterinary Pharmaceuticals
Description

Veterinary pharmaceutical products manufactured by SALF for animal health applications, produced in-house and supplied to veterinary clinics, animal operations, and animal-health distributors.

3Medical equipment
CategoryMedical Devices
Description

Medical devices and equipment manufactured by SALF as part of its product portfolio, intended for healthcare facilities and medical supply buyers.

No data
Peers10 records
TypeEmerging player
Description

Veterinary diagnostics and specialty medical device company. Comparable to SALF's medical equipment line in the animal-health segment.

TypeRegional player
Description

Italy-headquartered private pharmaceutical company with diversified pharma, diagnostics, and healthcare businesses. Comparable as a large privately held Italian peer with diversified healthcare manufacturing.

TypeDirect peer
Description

French global veterinary pharmaceutical group combining veterinary drugs, vaccines, and specialty pharma. Comparable to SALF's mix of veterinary drugs and broader pharmaceutical manufacturing in Europe.

TypeBroad incumbent
Description

Global leader in animal health and veterinary pharmaceuticals. Directly comparable to SALF's veterinary drugs line and serves as the scale benchmark SALF competes against in the veterinary segment.

TypeBroad incumbent
Description

Large global animal health company with a broad veterinary pharmaceutical and vaccine portfolio. Comparable to SALF's veterinary drugs line and sets the competitive benchmark for global veterinary scale.

TypeDirect peer
Description

UK-based specialty veterinary pharmaceuticals company focused on companion-animal therapeutics. Comparable to SALF in targeting specialty veterinary drug segments with a European base.

TypeDirect peer
Description

France-based global veterinary pharmaceutical company with a diversified animal-health and pharmaceutical product portfolio. Closely comparable to SALF in combining veterinary drugs with adjacent pharmaceutical offerings at a similar mid-cap scale.

TypeRegional player
Description

Private Italian pharmaceutical group with R&D-driven specialty pharma and rare-disease franchises. Comparable to SALF in being a privately held, R&D-active Italian pharma manufacturer.

TypeDirect peer
Description

Independent European veterinary pharmaceutical company headquartered in France. Comparable mid-size European competitor with overlapping veterinary drug and animal health portfolios.

TypeRegional player
Description

Italy-based mid-cap pharmaceutical company focused on specialty and rare diseases. Comparable as a fellow Italian mid-size pharma manufacturer operating from the same domestic cluster.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SALF

Pharmaceutical Manufacturingsalfspa.it

SALF is a Bergamo, Italy-based pharmaceutical manufacturer founded in 1921 that develops and produces medicines, veterinary drugs, and medical equipment through in-house research, employing 101-250 people.

What SALF does

SALF is a privately-held Italian pharmaceutical manufacturer headquartered in Bergamo, Italy, founded in 1921. With a workforce of 101–250 employees, the company operates as a mid-sized for-profit manufacturer producing human medicines, veterinary drugs, and medical equipment, supported by in-house ongoing research. Its product portfolio therefore spans three regulated categories — ethical/generic pharmaceuticals, animal health products, and medical devices — implying an integrated R&D-to-manufacturing operating model within a single Italian site.

The company's business model is anchored in regulated B2B and B2B2C distribution of pharmaceutical and veterinary products and medical devices, but no specific pricing model, channel structure, customer mix, or revenue mechanic was returned in the available data. SALF's public website (salfspa.it) did not yield substantive content during this data collection — the source page displayed only a loading/verification message — and consequently fields covering products, certifications, partnerships, management team, funding, M&A, AI capability, and customer base returned no values.

Given the thinness of the input, claims about market positioning, revenue scale, geographic footprint, capital structure, or competitive strategy cannot be substantiated beyond the firmographic facts above. Any further analysis would require access to the company's filings, distributor agreements, or audited financials, none of which were provided.

SALF firmographics

Firmographics
Name
SALF
Website
https://salfspa.it
Company type
Private
Founded year
1921
Headcount range
101–250 employees
Short description
SALF is a Bergamo, Italy-based pharmaceutical manufacturer founded in 1921 that develops and produces medicines, veterinary drugs, and medical equipment through in-house research, employing 101-250 people.
Ownership category
akta.pro rank

SALF industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid) (HLAMAEAG)
akta.pro secondary industry
Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers) (HLAMAFAF)

Keywords

  • Pharmaceutical manufacturing
  • Veterinary medicines
  • Medical equipment
  • Human medicines production
  • Pharmaceutical research

Where SALF is headquartered

Location

Headquarters

HQ city
Bergamo
HQ country
Italy
HQ region
Europe

Markets served

SALF business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Others

SALF product offering

Product offering

Core offering

SALF is a pharmaceutical manufacturer that develops, produces, and supplies human medicines, veterinary drugs, and medical equipment. The company's offering is built on ongoing in-house pharmaceutical research, formulation, and manufacturing capabilities, delivering finished pharmaceutical and medical products to healthcare and animal health markets.

Differentiator

Problem solved

Functional benefit

Products and services

  • Human medicines Pharmaceutical products manufactured by SALF for human therapeutic use, produced through ongoing research and produced at the company's Bergamo, Italy facility for distribution to healthcare buyers.
  • Veterinary drugs Veterinary pharmaceutical products manufactured by SALF for animal health applications, produced in-house and supplied to veterinary clinics, animal operations, and animal-health distributors.
  • Medical equipment Medical devices and equipment manufactured by SALF as part of its product portfolio, intended for healthcare facilities and medical supply buyers.

Companies that use SALF

Customer profile

Ideal customer profiles1 record

SALF technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

SALF competitors and assessment

Company assessment

Emerging players

Regional players

  • Menarini Group: Italy-headquartered private pharmaceutical company with diversified pharma, diagnostics, and healthcare businesses. Comparable as a large privately held Italian peer with diversified healthcare manufacturing.
  • Chiesi Farmaceutici: Private Italian pharmaceutical group with R&D-driven specialty pharma and rare-disease franchises. Comparable to SALF in being a privately held, R&D-active Italian pharma manufacturer.
  • Recordati: Italy-based mid-cap pharmaceutical company focused on specialty and rare diseases. Comparable as a fellow Italian mid-size pharma manufacturer operating from the same domestic cluster.

Direct peers

  • Ceva Santé Animale: French global veterinary pharmaceutical group combining veterinary drugs, vaccines, and specialty pharma. Comparable to SALF's mix of veterinary drugs and broader pharmaceutical manufacturing in Europe.
  • Dechra Pharmaceuticals: UK-based specialty veterinary pharmaceuticals company focused on companion-animal therapeutics. Comparable to SALF in targeting specialty veterinary drug segments with a European base.
  • Virbac: France-based global veterinary pharmaceutical company with a diversified animal-health and pharmaceutical product portfolio. Closely comparable to SALF in combining veterinary drugs with adjacent pharmaceutical offerings at a similar mid-cap scale.
  • Vetoquinol: Independent European veterinary pharmaceutical company headquartered in France. Comparable mid-size European competitor with overlapping veterinary drug and animal health portfolios.

Broad incumbents

  • Zoetis: Global leader in animal health and veterinary pharmaceuticals. Directly comparable to SALF's veterinary drugs line and serves as the scale benchmark SALF competes against in the veterinary segment.
  • Elanco Animal Health: Large global animal health company with a broad veterinary pharmaceutical and vaccine portfolio. Comparable to SALF's veterinary drugs line and sets the competitive benchmark for global veterinary scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

SALF social profiles

Digital presence

SALF financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SALF leadership team

Management profile

Number of profiles

SALF funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SALF M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SALF

What does SALF do?

SALF is a pharmaceutical manufacturer that develops, produces, and supplies human medicines, veterinary drugs, and medical equipment. The company's offering is built on ongoing in-house pharmaceutical research, formulation, and manufacturing capabilities, delivering finished pharmaceutical and medical products to healthcare and animal health markets.

When was SALF founded?

SALF was founded in 1921. It employs 101 to 250 people.

Where is SALF based?

SALF is headquartered in Bergamo, Italy, in the Europe region.

Who are SALF's main competitors?

Heska (now part of Mars Petcare / Antech) is listed as an emerging player. Regional players are Menarini Group, Chiesi Farmaceutici and Recordati. Direct peers are Ceva Santé Animale, Dechra Pharmaceuticals, Virbac and Vetoquinol. Broad incumbents are Zoetis and Elanco Animal Health.

Does SALF have an API?

No public API is recorded for SALF.

What industry is SALF in?

SALF's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAMAEAG, Endocrinology & Metabolic Drugs (e.g., Diabetes, Thyroid), with a secondary code of HLAMAFAF, Wound Care, Bandaging & Consumables (Dressings, Sutures, Staplers). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales